Moximed Named One of the “Fierce 15” Medical Devices 2015

14 October 2015

The scoop: Moximed is shooting to change the standard of care for patients with knee osteoarthritis (OA) with its KineSpring Knee Implant System. Normally, patients with OA try to get by with pain medication and knee braces before opting for joint-altering surgery. Moximed’s product targets patients with mild and moderate knee OA whose pain is […]

Continue Reading

Visterra’s Monoclonal Antibody Demonstrated Significant Antiviral Activity in Phase 2a

05 October 2015

Visterra’s Monoclonal Antibody in Development for the Treatment of Influenza A, VIS410, Demonstrated Significant Antiviral Activity and Reduced Duration of Respiratory Symptoms in Phase 2a Challenge Study – Study Achieved its Primary Endpoint of Reduction in Viral Shedding; Treatment with VIS410 Resulted in a 92% Reduction of Virus vs. Placebo –Study Results Support Further Development of VIS410 in Hospitalized Patients  with Influenza A Cambridge, MA – October 5, 2015 Visterra, Inc., a clinical-stage biotechnology company […]

Continue Reading

Vertex Venture Holdings gets funds to go global

Armed with a war chest of US$600 million (S$857 million), Singapore’s largest and oldest venture capital firm is going global. The infusion of cash will allow Vertex Venture Holdings to invest in start-ups in the hot seats of innovation and technological disruption – United States, Israel and China – after having been mainly focused on […]

Continue Reading